Housing inventory is up in the D.C. metro area but pending sales are down, likely due to the impact of DOGE and federal ...

It's rare for someone to have their cake and eat it, too. Dave Portnoy became an exception - an incredibly wealthy one - in ...

Being spliced on to Regeneron will free the genetic testing company from its fatal dependence on sporadic revenue ...

Despite ongoing competition and the threat of heightened regulation, we think DraftKings' stout technology and product offering produce a brand advantage, the source of its narrow moat. DraftKings' in ...

Scale Computing CEO Jeff Ready tells CRN that new tools in Scales’ edge computing technology make application deployment and ...

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

After acquiring 23andMe, Regeneron Pharmaceuticals has said it will protect user data as it uses DNA data for drug ...

Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...

These aren’t just strategies for survival—they're the building blocks for creating programs that thrive in an increasingly ...

Simbe Vision includes inventory features such as stock detection, product recognition, similarity detection, and ...

We sat down with the founder and CEO of RebelMouse to talk about the platform’s origin, its unique approach to innovation, ...

American biotechnology firm Regeneron Pharmaceuticals is buying the personal genetics brand 23andMe after submitting a winning bid of $256 million in a bankruptcy auction, according to a Monday ...